NCT00271050View on ClinicalTrials.gov

External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

June 30, 2010

Conditions
Lymphoma, B-Cell
Interventions
OTHER

external beam radiotherapy plus 90-Y ibritumomab tiuxetan

combination of EBRT followed by radioimmunotherapeutic 90-Y ibritumomab tiuxetan

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT00271050 - External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter